Comparable stake leader
ARMISTICE CAPITAL, LLC
SEC ownership of Vincerx Pharma, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001796129.
Disclosed value leader
Christopher P. Lowe
Comparable rows
2/19
Latest evidence
31 Mar 2025
- Parsed ownership sources
-
13D/G and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
ARMISTICE CAPITAL, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
2 of 19
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
ARMISTICE CAPITAL, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
31 Mar 2025
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001796129
- Issuer location
- Palo Alto, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Vincerx Pharma, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
Christopher P. Lowe
Comparable rows
2/19
Latest evidence
31 Mar 2025
13D/G
3/4/5
Lead comparable stake: 5%
17 rows are not safely comparable across share classes.
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-8 of 19 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.
2 of 19 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 2
ARMISTICE CAPITAL, LLC
5%
Prosight Management, LP
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 19 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$19,244
274,908 shares
|
-$294,015 | 31 Mar 2025 |
| Prosight Management, LP |
13D/G
|
5%
|
$7,823
111,755 shares
|
$0 | 31 Dec 2024 |
| Rubric Capital Management LP |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
2,107,000 shares
|
— | 20 Jan 2022 |
| Andrew I. McDonald |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
—
15,000 shares
|
— | 26 May 2022 |
| Christopher P. Lowe |
3/4/5
Director
|
—
class O/S missing
|
$37,972
40,000 shares
|
— | 24 Aug 2022 |
| Alexander A. Seelenberger |
3/4/5
Chief Financial Officer
|
—
mixed-class rows
|
$28,745
155,280 shares
mixed-class rows
|
— | 12 Aug 2024 |
| SAGE RHINO CAPITAL LLC |
13D/G
|
—
class O/S missing
|
$426
4,260 shares
|
$0 | 29 Jan 2025 |
| Ahmed Hamdy MD |
3/4/5
Chief Executive Officer, Director
|
—
class O/S missing
|
—
200,000 shares
|
— | 12 Aug 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 02 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-16 of 16 reporting-owner rows connected to Vincerx Pharma, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
16
Largest Forms 3/4/5 holder
Christopher P. Lowe
Net 12M change
$0
Latest report
20 Dec 2024
Recent insider transactions for Vincerx Pharma, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.